LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. QUICKLY (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its latest product, RMBNucleus™ Mold Alarm, which will be used to rapidly Detection of environmental influences was developed forms in the pharmaceutical manufacturing process. RMBNucleus™ Mold Alarm is expected to be available on the Growth Direct® system before the end of 2022.
The slow detection and confirmation of mold contamination remains a critical environmental monitoring challenge in pharmaceutical manufacturing facilities and can compromise products and endanger patients. RMBNucleus™ Mold Alarm, a new software offering for use with the Growth Direct® system, adds rapid detection that allows for early intervention.
“RMB is committed to supporting life-saving therapies, patient after patient,” said Rob Spignesi, President and CEO of Rapid Micro Biosystems. “We are pleased to introduce RMBNucleus™ Mold Alarm, which enables our Growth Direct® system to quickly detect mold in the pharmaceutical manufacturing process environment. Like each of our products in the Growth Direct® system, RMBNucleus™ Mold Alarm has improvements in data integrity and generates automatic alerts at the first sign of mold detection in just one day, allowing for early intervention and reduced risk of contamination.”
Rapid Micro Biosystems will be attending the 2022 PDA Pharmaceutical Microbiology Conference October 10-12, 2022 in Washington, DC. The company will host a booth with a ready-to-run Growth Direct® system to demonstrate its rapid detection technology and the benefits of automation and digitization in the quality control laboratory.
Investors and other interested parties are invited to register to attend the conference at:
